» Articles » PMID: 32586355

Mitochondria Transfer Enhances Proliferation, Migration, and Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cell and Promotes Bone Defect Healing

Overview
Publisher Biomed Central
Date 2020 Jun 27
PMID 32586355
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bone marrow-derived mesenchymal stem cell (BMSC) transplantation is considered a promising therapeutic approach for bone defect repair. However, during the transplantation procedure, the functions and viability of BMSCs may be impaired due to extended durations of in vitro culture, aging, and disease conditions of patients. Inspired by spontaneous intercellular mitochondria transfer that naturally occurs within injured tissues to rescue cellular or tissue function, we investigated whether artificial mitochondria transfer into pre-transplant BMSCs in vitro could improve cellular function and enhance their therapeutic effects on bone defect repair in situ.

Methods: Mitochondria were isolated from donor BMSCs and transferred into recipient BMSCs of the same batch and passage. Subsequently, changes in proliferative capacity and cell senescence were evaluated by live cell imaging, Cell Counting Kit-8 assay, cell cycle analysis, Ki67 staining, qPCR and Western blot analysis of c-Myc expression, and β-galactosidase staining. Migration ability was evaluated by the transwell migration assay, wound scratch healing, and cell motility tests. Alkaline phosphatase (ALP) staining, Alizarin Red staining, and combined with qPCR and Western blot analyses of Runx2 and BMP2 were performed to elucidate the effects of mitochondria transfer on the osteogenic potential of BMSCs in vitro. After that, in vivo experiments were performed by transplanting mitochondria-recipient BMSCs into a rat cranial critical-size bone defect model. Micro CT scanning and histological analysis were conducted at 4 and 8 weeks after transplantation to evaluate osteogenesis in situ. Finally, in order to establish the correlation between cellular behavioral changes and aerobic metabolism, OXPHOS (oxidative phosphorylation) and ATP production were assessed and inhibition of aerobic respiration by oligomycin was performed.

Results: Mitochondria-recipient BMSCs exhibited significantly enhanced proliferation and migration, and increased osteogenesis upon osteogenic induction. The in vivo results showed more new bone formation after transplantation of mitochondria-recipient BMSCs in situ. Increased OXPHOS activity and ATP production were observed, which upon inhibition by oligomycin attenuated the enhancement of proliferation, migration, and osteogenic differentiation induced by mitochondria transfer.

Conclusions: Mitochondria transfer is a feasible technique to enhance BMSC function in vitro and promote bone defect repair in situ through the upregulation of aerobic metabolism. The results indicated that mitochondria transfer may be a novel promising technique for optimizing stem cell therapeutic function.

Citing Articles

Metabolic reprogramming in cancer and senescence.

Zhang Y, Tang J, Jiang C, Yi H, Guang S, Yin G MedComm (2020). 2025; 6(3):e70055.

PMID: 40046406 PMC: 11879902. DOI: 10.1002/mco2.70055.


Engineered mitochondria in diseases: mechanisms, strategies, and applications.

Li M, Wu L, Si H, Wu Y, Liu Y, Zeng Y Signal Transduct Target Ther. 2025; 10(1):71.

PMID: 40025039 PMC: 11873319. DOI: 10.1038/s41392-024-02081-y.


METTL14 Promotes the Osteogenic Differentiation of Human Bone Marrow Stromal Cells via m6A-Dependent Stabilization of USP7 mRNA.

Leng Y, Liu Z, Min J, Ke Q, Shao Y, Lai J Biochem Genet. 2025; .

PMID: 39815132 DOI: 10.1007/s10528-024-10999-9.


LncRNA NR_045147 modulates osteogenic differentiation and migration in PDLSCs via ITGB3BP degradation and mitochondrial dysfunction.

Long L, Zhang C, He Z, Liu O, Yang H, Fan Z Stem Cells Transl Med. 2024; 14(2).

PMID: 39674578 PMC: 11878762. DOI: 10.1093/stcltm/szae088.


MiR-223-3p Promotes Osteoporosis Progression by Repressing Osteogenic Differentiation via Targeting FHL1/Wnt/β-catenin Signaling.

Shi K, Wei J, Chen J Cell Biochem Biophys. 2024; .

PMID: 39613991 DOI: 10.1007/s12013-024-01579-0.


References
1.
Lien C, Chih-Yuan Ho K, Lee O, Blunn G, Su Y . Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells. J Bone Miner Res. 2008; 24(5):837-48. DOI: 10.1359/jbmr.081257. View

2.
van Zoelen E, Duarte I, Hendriks J, van der Woning S . TGFβ-induced switch from adipogenic to osteogenic differentiation of human mesenchymal stem cells: identification of drug targets for prevention of fat cell differentiation. Stem Cell Res Ther. 2016; 7(1):123. PMC: 5000485. DOI: 10.1186/s13287-016-0375-3. View

3.
Sabali M, Mangano A, Lianos G, Boni L, Dionigi G, Mangano A . Bone regeneration using mesenchymal stem cells: challenges and future perspectives in regenerative surgery. Regen Med. 2015; 10(5):543-7. DOI: 10.2217/rme.15.35. View

4.
Morrish F, Isern N, Sadilek M, Jeffrey M, Hockenbery D . c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. Oncogene. 2009; 28(27):2485-91. PMC: 2779836. DOI: 10.1038/onc.2009.112. View

5.
Si Y, Zhao Y, Hao H, Fu X, Han W . MSCs: Biological characteristics, clinical applications and their outstanding concerns. Ageing Res Rev. 2010; 10(1):93-103. DOI: 10.1016/j.arr.2010.08.005. View